Preventing the Financing of Illegal Synthetic Drugs Act
Latest Action
Became Public Law No: 118-79.
Official Summary
Official summary has not been imported yet.
GovScope Watchdog™
AI Government Intelligence™The Preventing the Financing of Illegal Synthetic Drugs Act, enacted as Public Law No: 118-79 on September 13, 2024, is a legislative measure aimed at addressing the financial mechanisms that support the production and distribution of illegal synthetic drugs. Although the full text and detailed summary are not provided, the bill's title and policy area indicate a focus on disrupting illegal drug financing through government operations and political measures. The bill was introduced in the House during the 118th Congress and ultimately became law, suggesting it passed both chambers and was signed by the President. However, the status is noted as Failed / Expired, indicating complexities in its legislative or implementation timeline.
This law targets the financial channels that enable illegal synthetic drug activities, aiming to strengthen government efforts in combating drug-related crime through financial oversight and regulation.
- The bill focuses on preventing the financing of illegal synthetic drugs, addressing a key aspect of drug enforcement.
- It was introduced in the House of Representatives during the 118th Congress and became Public Law No: 118-79 on September 13, 2024.
- The policy area is Government Operations and Politics, indicating involvement of federal agencies and regulatory frameworks.
['Federal law enforcement agencies involved in drug interdiction and financial crime investigation', 'Regulatory bodies overseeing financial transactions and anti-money laundering efforts', 'Communities affected by illegal synthetic drug distribution']
['The absence of the full bill text limits understanding of specific enforcement mechanisms and funding requirements', 'Potential challenges in implementation due to coordination among multiple agencies', 'Possible tradeoffs between financial privacy and regulatory oversight']
The bill was introduced and passed during the 118th Congress, reflecting ongoing legislative efforts to combat illegal synthetic drugs through financial regulation. The designation as Failed / Expired may indicate procedural or timing issues post-enactment, but the bill ultimately became law as Public Law No: 118-79.
Hidden impact flags detected: 2
GovScope reviewed 2 policy-risk categories. Hover for a quick definition. Click detected flags for bill-specific details.
['Enhanced financial oversight may lead to improved detection of other financial crimes beyond synthetic drug financing.', "Increased regulatory requirements could impact financial institutions' compliance costs and operational procedures.", 'Communities affected by synthetic drug distribution may experience changes in drug availability or enforcement intensity.']
The lack of a full bill text and official summary limits detailed analysis of specific provisions, funding, and enforcement mechanisms. Transparency about the bill's implementation status and the reasons for its 'Failed / Expired' designation despite becoming law would aid public understanding. Monitoring the coordination among agencies and the balance between enforcement and privacy protections will be important for oversight.
GovScope Intelligence Roadmap
Future bill intelligence will connect sponsors, committee referrals, related votes, campaign finance, disclosures, and stock trades into one legislative intelligence view.